{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:39:50Z","timestamp":1790390390515,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T00:00:00Z","timestamp":1384905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00216-013-7446-4","type":"journal-article","created":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T09:28:06Z","timestamp":1384853286000},"page":"249-265","source":"Crossref","is-referenced-by-count":33,"title":["Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments"],"prefix":"10.1007","volume":"406","author":[{"given":"Anna","family":"Alekseeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benito","family":"Casu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cassinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Guerrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giangiacomo","family":"Torri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Naggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,20]]},"reference":[{"key":"7446_CR1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","volume":"337","author":"JI Weitz","year":"1997","unstructured":"Weitz JI (1997) Low-molecular weight heparins. N Engl J Med 337:688\u2013698","journal-title":"N Engl J Med"},{"key":"7446_CR2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1055\/s-2007-982078","volume":"33","author":"M Guerrini","year":"2007","unstructured":"Guerrini M, Guglieri S, Naggi A, Sasisekharan R, Torri G (2007) Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy. Semin Thromb Hemost 33:478\u2013487, and references therein","journal-title":"Semin Thromb Hemost"},{"key":"7446_CR3","unstructured":"Casu B (2005) In: Garg HG, Linhardt RJ, Hales CA (ed.s) Chemistry and biology of heparin and heparan sulfate, Elsevier, Amsterdam, and references therein"},{"key":"7446_CR4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd724","volume":"1","author":"R Lever","year":"2002","unstructured":"Lever R, Page CP (2002) Novel drug development opportunities for heparin. Nat Rev Drug Discov 1:140\u2013148","journal-title":"Nat Rev Drug Discov"},{"key":"7446_CR5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrc1649","volume":"5","author":"MM Fuster","year":"2005","unstructured":"Fuster MM, Esko JD (2005) The sweet and sour of cancer: glycans as novel therapeutic agents. Nat Rev Cancer 5:526\u2013542","journal-title":"Nat Rev Cancer"},{"key":"7446_CR6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000175157","volume":"36","author":"B Casu","year":"2007","unstructured":"Casu B, Vlodavsky I, Sanderson RD (2007) Non-anticoagulant heparins and inhibition of cancer. Pathophysiol Haemost Thromb 36:195\u2013203","journal-title":"Pathophysiol Haemost Thromb"},{"key":"7446_CR7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.matbio.2010.04.003","volume":"29","author":"B Casu","year":"2010","unstructured":"Casu B, Naggi A, Torri G (2010) Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer. Matrix Biol 29:442\u2013452, and references therein","journal-title":"Matrix Biol"},{"key":"7446_CR8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0014-5793(76)80592-3","volume":"66","author":"M H\u00f6\u00f6k","year":"1976","unstructured":"H\u00f6\u00f6k M, Bj\u00f6rk I, Hopwood J, Lindahl U (1976) Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin. FEBS Lett 66:90\u201393","journal-title":"FEBS Lett"},{"key":"7446_CR9","unstructured":"Naggi A (2005) In: Garg HG, Linhardt RJ, Hales CA (ed.s) Chemistry and biology of heparin and heparan sulfate, Elsevier, Amsterdam, and references therein"},{"key":"7446_CR10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1160\/TH06-05-0289","volume":"96","author":"SA Mousa","year":"2006","unstructured":"Mousa SA, Linhardt R, Francis JL, Amirkhosravi A (2006) Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin. Thromb Haemost 96:816\u2013821","journal-title":"Thromb Haemost"},{"key":"7446_CR11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0065-2318(06)60005-X","volume":"60","author":"AS Perlin","year":"2008","unstructured":"Perlin AS (2008) Glycol-cleavage oxidation. Adv Carbohydr Chem Biochem 60:183\u2013250","journal-title":"Adv Carbohydr Chem Biochem"},{"key":"7446_CR12","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0008-6215(02)00229-X","volume":"337","author":"T Islam","year":"2002","unstructured":"Islam T, Butler M, Sikkander SA, Toida T, Linhardt RJ (2002) Further evidence that periodate cleavage of heparin occurs primarily through the antithrombin binding site. Carbohydr Res 337:2239\u20132243","journal-title":"Carbohydr Res"},{"key":"7446_CR13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ab.2012.11.011","volume":"434","author":"A Alekseeva","year":"2013","unstructured":"Alekseeva A, Casu B, Torri G, Pierro S, Naggi A (2013) Profiling glycol-split heparins by high-performance liquid chromatography\/mass spectrometric analysis of their heparinase-generated oligosaccharides. Anal Biochem 434:112\u2013122","journal-title":"Anal Biochem"},{"key":"7446_CR14","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.1021\/bi020118n","volume":"41","author":"B Casu","year":"2002","unstructured":"Casu B, Guerrini M, Naggi A, Perez M, Torri G, Ribatti D, Carminati P, Giannini G, Penco S, Pisano C, Belleri M, Resnati M, Presta M (2002) Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors. Biochemistry 41:10519\u201310528","journal-title":"Biochemistry"},{"key":"7446_CR15","doi-asserted-by":"crossref","first-page":"12103","DOI":"10.1074\/jbc.M414217200","volume":"280","author":"A Naggi","year":"2005","unstructured":"Naggi A, Casu B, Perez M, Torri G, Cassinelli G, Penco S, Pisano C, Giannini G, Ishai-Michaeli R, Vlodavsky I (2005) Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol-splitting. J Biol Chem 280:12103\u201312113","journal-title":"J Biol Chem"},{"key":"7446_CR16","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1096\/fj.07-8450com","volume":"21","author":"N Hostetter","year":"2007","unstructured":"Hostetter N, Naggi A, Torri G, Ishai-Michaeli R, Casu B, Vlodavsky I, Borsig L (2007) P-selectin and heparanase-dependent antimetastatic activity of non-anticoagulant heparins. FASEB J 21:3562\u20133572","journal-title":"FASEB J"},{"key":"7446_CR17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4269\/ajtmh.2011.10-0256","volume":"84","author":"AM Leitgeb","year":"2011","unstructured":"Leitgeb AM, Blomqvist K, Cho-Ngwa F, Samje M, Nde P, Titanji V, Wahlgrene M (2011) Low anticoagulant heparin disrupts Plasmodium falciparum rosettes in fresh clinical isolates. Am J Trop Med Hyg 84:390\u2013396","journal-title":"Am J Trop Med Hyg"},{"key":"7446_CR18","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1080\/00016340903176818","volume":"88","author":"G Ekman-Ordeberg","year":"2009","unstructured":"Ekman-Ordeberg G, Hellgren M, Akerud A, Andersson E, Dubicke A, Sennstr\u00f6m M, Bystr\u00f6m B, Tzortzatos G, Gomez MF, Edlundl M, Lindahl U, Malmstr\u00f6m (2009) A Low molecular weight heparin stimulates myometrial contractility and cervical remodeling in vitro. Acta Obstetr et Gynecol Scand 88:984\u2013989","journal-title":"Acta Obstetr et Gynecol Scand"},{"key":"7446_CR19","first-page":"0853","volume":"2","author":"AM Vogt","year":"2006","unstructured":"Vogt AM, Pettersson F, Moll K, Johnsson C, Normark J, Ribacke U, Egwang TG, Ekre H-P, Spilmann D, Chen Q, Wahlgren M (2006) Release of sequestered malaria parasites upon injection of a glycosaminoglycan. PLoS Pathog 2:0853\u20130863","journal-title":"PLoS Pathog"},{"key":"7446_CR20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/01.CIR.99.5.682","volume":"99","author":"JI Weitz","year":"1999","unstructured":"Weitz JI, Young E, Johnston M, Stafford AR, Fredenburgh JC, Hirsh J (1999) Vasoflux, a new anticoagulant with a novel mechanism of action circulation. Circulation 99:682\u2013689","journal-title":"Circulation"},{"key":"7446_CR21","doi-asserted-by":"crossref","first-page":"e21106","DOI":"10.1371\/journal.pone.0021106","volume":"6","author":"H Zhou","year":"2011","unstructured":"Zhou H, Roy S, Cochran E, Zouaoui R, Chu CL, Duffner J, Zhao G, Smith S, Galcheva-Gargova Z, Karlgren J, Dussault N, Kwan RYQ, Moy E, Barnes M, Long A, Hohan C, Qi YW, Shriver Z, Ganguly T, Schultes B, Venkataraman G, Kishimoto TK (2011) M402, a novel heparan sulfate mimetic, targets multiple pathways in tumor progression and metastasis. PLosONE 6:e21106. doi: 10.1371\/journal.pone.0021106","journal-title":"PLosONE"},{"key":"7446_CR22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1021\/jm101381k","volume":"54","author":"Z Xiao","year":"2011","unstructured":"Xiao Z, Tappen BR, Ly M, Zhao W, Canova LP, Guan H, Linhardt RJ (2011) Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin. J Med Chem 54:603\u2013610","journal-title":"J Med Chem"},{"key":"7446_CR23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/abio.1999.4230","volume":"274","author":"M Iacomini","year":"1999","unstructured":"Iacomini M, Casu B, Guerrini M, Naggi A, Pirola A, Torri G (1999) \u201cLinkage region\u201d sequence of heparin and heparan sulfate: detection and quantification by nuclear magnetic resonance spectroscopy. Anal Biochem 274:50\u201358, and references therein","journal-title":"Anal Biochem"},{"key":"7446_CR24","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1021\/jm00168a017","volume":"33","author":"RJ Linhardt","year":"1990","unstructured":"Linhardt RJ, Loganathan D, Al-Hakim A, Wang H-M, Walenga JM, Hoppensteadt D, Fareed J (1990) Oligosaccharide mapping of low-molecular weight heparins: structure and activity differences. J Med Chem 33:1639\u20131645","journal-title":"J Med Chem"},{"key":"7446_CR25","unstructured":"Capila I, Gunay NS, Shriver Z, Venkataraman G (2005) In: Garg HG, Linhardt RJ, Hales CA (ed.s) Chemistry and biology of heparin and heparan sulfate, Elsevier, Amsterdam"},{"key":"7446_CR26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.chroma.2013.01.011","volume":"1292","author":"DJ Langeslay","year":"2013","unstructured":"Langeslay DJ, Urso E, Gardini C, Naggi A, Torri G, Larive CK (2013) Reversed-phase ion-pair ultra-high-performance-liquid chromatography-mass spectrometry for fingerprinting low-molecular-weight heparins. J Chromatogr A 1292:201\u2013210","journal-title":"J Chromatogr A"},{"key":"7446_CR27","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1021\/ac702235u","volume":"80","author":"AK Korir","year":"2008","unstructured":"Korir AK, Limtiaco JF, Gutierrez SM, Larive CK (2008) Ultraperformance ion-pair liquid chromatography coupled with electrospray time-of flight mass spectrometry for compositional profiling and quantification of heparin and heparan sulphate. Anal Chem 80:1297\u20131306","journal-title":"Anal Chem"},{"key":"7446_CR28","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.1021\/ja0178867","volume":"124","author":"B Kuberan","year":"2002","unstructured":"Kuberan B, Lech M, Zhang L, Wu LZ, Beeler DL, Rosenberg R (2002) Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography-microelectrospray ionization time-of-flight mass spectrometry. J Am Chem Soc 124:8707\u20138718","journal-title":"J Am Chem Soc"},{"key":"7446_CR29","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1021\/ac802770r","volume":"81","author":"CE Doneanu","year":"2009","unstructured":"Doneanu CE, Chen W, Geber JC (2009) Analysis of oligosaccharides derived from heparin by ion-pair reverse-phase chromatography\/mass spectrometry. Anal Chem 81:3485\u20133499","journal-title":"Anal Chem"},{"key":"7446_CR30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jpba.2012.04.033","volume":"67\u201368","author":"B Wang","year":"2012","unstructured":"Wang B, Buhse LF, Al-Hakim A, Boyne Ii MT, Keire DA (2012) Characterization of currently marketed heparin products: analysis of heparin digests by RPIP-UHPLC-QTOF-MS. J Pharm Biomed Anal 67\u201368:42\u201350","journal-title":"J Pharm Biomed Anal"},{"key":"7446_CR31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1432-1033.1981.tb05343.x","volume":"116","author":"WF Vann","year":"1981","unstructured":"Vann WF, Schmidt MA, Jann B, Jann K (1981) The structure of the capsular polysaccharide (K5 Antigenn) of urinary-tract-infective Escherichia coli 010:K5:H4. Eur J Biochem 116:359\u2013364","journal-title":"Eur J Biochem"},{"key":"7446_CR32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ab.2004.10.012","volume":"337","author":"M Guerrini","year":"2005","unstructured":"Guerrini M, Naggi A, Guglieri S, Santarsiero R, Torri G (2005) Complex glycosaminoglycans: profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy. Anal Biochem 337:35\u201347","journal-title":"Anal Biochem"},{"key":"7446_CR33","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/jms.723","volume":"39","author":"J Henriksen","year":"2004","unstructured":"Henriksen J, Ringborg LH, Roepstorrf P (2004) On-line size-exclusion chromatography\/mass spectrometry of low molecular mass heparin. J Mass Spec 39:1305\u20131312","journal-title":"J Mass Spec"},{"key":"7446_CR34","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1160\/TH09-02-0081","volume":"102","author":"A Bisio","year":"2009","unstructured":"Bisio A, Vecchietti D, Citterio L, Guerrini M, Raman R, Bertini S, Eisele G, Naggi A, Sasisekharan R (2009) Structural features of low-molecular weight heparins affecting their affinity to antithrombin. Thromb Haemost 102:865\u2013873","journal-title":"Thromb Haemost"},{"key":"7446_CR35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/bi00803a005","volume":"9","author":"JE Shively","year":"1970","unstructured":"Shively JE, Conrad HE (1970) Stoichiometry of the nitrous acid deaminative cleavage of model amino sugar glycosides and glycosaminoglycuronans. Biochem 9:33\u201343","journal-title":"Biochem"},{"key":"7446_CR36","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1139\/v85-071","volume":"63","author":"HH Baer","year":"1985","unstructured":"Baer HH, Astles DJ, Chin H-C, Siemsen L (1985) The formation of branched-chain deoxypentofuranosides by ring contraction in the reductive desulfonyloxylation of hexopyranoside p-toluenesulfonates. Can J Chem 63:432\u2013439","journal-title":"Can J Chem"},{"key":"7446_CR37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0008-6215(00)81823-6","volume":"30","author":"D Horton","year":"1973","unstructured":"Horton D, Philips KD (1973) The nitrous acid deamination of glycosides and acetates of 2-amino-2-deoxy-d-glucose. Carbohyd Res 30:367\u2013374","journal-title":"Carbohyd Res"},{"key":"7446_CR38","doi-asserted-by":"crossref","unstructured":"Thanawiroon C, Rice KG, Toida T, Linhardt RJ (2004) Liquid chromatography\/mass spectrometry sequencing approach for highly sulfated heparin-derived oligosaccharides. J Biol Chem 279:2608\u20132615","DOI":"10.1074\/jbc.M304772200"},{"key":"7446_CR39","doi-asserted-by":"crossref","unstructured":"Rudd TR, Macchi E, Muzi L, Ferro M, Gaudesi D, Torri G, Casu B, Guerrini M, Yates EA (2013) Unravelling structural information from complex mixtures utilising correlation spectroscopy applied to HSQC spectra. Anal Chem. Anal Chem 85:7487\u20137493","DOI":"10.1021\/ac4014379"},{"key":"7446_CR40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0968-0004(86)90011-3","volume":"11","author":"U Lindahl","year":"1986","unstructured":"Lindahl U, Feingold DS, Roden L (1986) Biosynthesis of heparin. Trends Biochem Sci 11:221\u2013225","journal-title":"Trends Biochem Sci"},{"key":"7446_CR41","doi-asserted-by":"crossref","unstructured":"Tone Y, Pedersen LC, Yamamoto T, Izumikawa T, Kitagawa H, Nishihara J, Tamura J, Negishi M, Sugahara K (2008) 2-O-Phosporylation of xylose and 6-O-sulfation of galactose in the protein linkage region of glucosaminoglycans influence the glucuronyltransferase-I activity involved in the linkage region synthesis. J Biol Chem 283:16801\u201316807","DOI":"10.1074\/jbc.M709556200"},{"key":"7446_CR42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0008-6215(96)90611-4","volume":"294","author":"EA Yates","year":"1996","unstructured":"Yates EA, Santini F, Guerrini M, Naggi A, Torri G, Casu B (1996) 1H and 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives. Carbohydr Res 294:15\u201327","journal-title":"Carbohydr Res"},{"key":"7446_CR43","unstructured":"Viskov C, Mourier P (2004) Method for quantitatively determining specific groups constituting heparins of low molecular weight heparins. US Pat Appl 2004\/0265943 A1"},{"key":"7446_CR44","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s00216-012-6045-0","volume":"403","author":"J Ozug","year":"2012","unstructured":"Ozug J, Wudyka S, Gunay NS, Beccati D, Lansing J, Wang J, Capila I, Shriver Z, Kaundinya GV (2012) Structural elucidation of the tetrasaccharide pool in enoxaparin sodium. Anal Bioanal Chem 403:2733\u20132744","journal-title":"Anal Bioanal Chem"},{"key":"7446_CR45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/glycob\/cwq123","volume":"21","author":"Z Xiao","year":"2011","unstructured":"Xiao Z, Zhao W, Yang B, Zhang Z, Guan H, Linhardt RJ (2011) Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-\u03b1-d-glucopyranose (1,4) 2-O-sulfo-\u03b1-l-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages. Glycobiol 21:13\u201322","journal-title":"Glycobiol"},{"key":"7446_CR46","doi-asserted-by":"crossref","first-page":"10365","DOI":"10.1073\/pnas.97.19.10365","volume":"97","author":"Z Shriver","year":"2000","unstructured":"Shriver Z, Sundaram M, Venkataraman G, Fareed J, Linhardt R, Biemann K, Sasisekharan R (2000) Cleavage of the antithrombin III binding site by heparinases and its implication in the generation of low-molecular weight heparin. Proc Natl Acad Sci U S A 97:10365\u201310370","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-013-7446-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-013-7446-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-013-7446-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T14:34:28Z","timestamp":1564756468000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-013-7446-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,20]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["7446"],"URL":"https:\/\/doi.org\/10.1007\/s00216-013-7446-4","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,20]]}}}